Stocktoria
INVO Fertility, Inc. IVF
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2008-11-11
INVO Fertility, Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8M | $6.6M | $3.0M | $822,196 | $4.2M | $1.0M | $1.5M | $494,375 | $282,145 | — |
| Gross profit | — | — | — | $490,673 | $4.0M | $948,526 | $1.3M | $404,008 | $230,191 | — |
| R&D expense | — | $4,880 | $165,945 | $544,043 | $216,430 | $398,426 | $0 | — | — | — |
| SG&A expense | $7.7M | $8.1M | $7.5M | $10.0M | $9.0M | $6.1M | $3.1M | $3.0M | $870,612 | — |
| Operating income | -$7.2M | -$6.6M | -$6.8M | -$10.6M | -$5.2M | -$5.5M | -$1.8M | -$2.6M | -$640,421 | — |
| Interest expense | — | $1.1M | $925,909 | $59,445 | $1.3M | $2.8M | $387,646 | $442,031 | $20,873 | — |
| Income tax | -$150,371 | $140,202 | $27,786 | $2,872 | $4,764 | $36 | $433 | $0 | $0 | — |
| Net income | -$23.3M | -$9.3M | -$8.0M | -$10.9M | -$6.7M | -$8.3M | -$2.2M | -$3.1M | -$702,163 | $18.2M |
| EPS (diluted) | $-214.64 | $-3782.65 | $-67.37 | $-17.97 | $-0.63 | $-1.52 | $-0.45 | $-0.02 | $0.00 | — |
| Operating cash flow | -$7.0M | -$3.0M | -$4.8M | -$6.6M | -$6.0M | -$4.8M | $1.4M | -$652,971 | -$181,270 | — |
| Free cash flow | -$7.1M | -$3.2M | -$5.2M | -$6.6M | -$6.4M | -$4.8M | $1.3M | -$672,371 | -$181,270 | — |
| Cash & equivalents | — | — | — | — | $5.7M | $10.1M | $1.2M | $212,243 | $25,759 | $39,649 |
| Inventory | $225,253 | $219,764 | $264,507 | $263,602 | $287,773 | $265,372 | $101,387 | $43,513 | $58,879 | $79,494 |
| Total assets | $20.2M | $46.1M | $18.5M | $4.1M | $10.5M | $10.9M | $1.8M | $777,347 | $266,413 | $194,498 |
| Total liabilities | $13.0M | $26.0M | $17.6M | $5.1M | $3.2M | $5.2M | $5.5M | $3.5M | $5.3M | $4.9M |
| Shareholders' equity | $7.2M | $12.6M | $892,825 | -$977,612 | $7.3M | $5.7M | -$3.7M | -$2.7M | -$5.0M | -$4.7M |
Growth · year-over-year · Revenue CAGR 49%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +4.3% | +117.2% | +267.4% | -80.2% | +301.1% | -29.9% | +199.4% | +75.2% | — | — |
| Net income growth | — | — | — | — | — | — | — | — | -103.9% | — |
| Free cash flow growth | — | — | — | — | — | -469.5% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.